251 – 260 of 393
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight
(
- Contribution to journal › Article
-
Mark
Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
(
- Contribution to journal › Article
-
Mark
Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males
(
- Contribution to journal › Article
-
Mark
Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker diabetic fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV
(
- Contribution to journal › Article
-
Mark
Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats
(
- Contribution to journal › Article
-
Mark
Alpha cell function in health and disease: influence of glucagon-like peptide-1
(
- Contribution to journal › Scientific review
-
Mark
Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice
(
- Contribution to journal › Article
-
Mark
Ny strategi vid typ 2-diabetes prövas i kliniska studier. Glukagonlik peptid 1 (GLP-1) påverkar sjukdomens grundorsaker
(
- Contribution to journal › Article
-
Mark
Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance?
(
- Contribution to journal › Article
-
Mark
Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.
(
- Contribution to journal › Article